Research ArticleClinical Studies
Continuity Unveiled: Evaluating Cytoreduction Outcomes for Advanced Ovarian Cancer Amidst the COVID-19 Era at an ESGO Designated Centre of Excellence
KONSTANTINOS KITSOS-KALYVIANAKIS, KONSTANTINOS PITSIKAKIS, MARIOS EVANGELOS MAMALIS, EVANGELOS KALAMPOKIS, YONG SHENG TAN, AMUDHA THANGAVELU, TIMOTHY BROADHEAD, DAVID NUGENT, DIEDERICK DEJONG and ALEXANDROS LAIOS
Anticancer Research June 2024, 44 (6) 2645-2652; DOI: https://doi.org/10.21873/anticanres.17071
KONSTANTINOS KITSOS-KALYVIANAKIS
1Department of Gynaecologic Oncology, ESGO Centre of Excellence for Ovarian Cancer Surgery, St James’s University Hospital, Leeds, U.K.;
KONSTANTINOS PITSIKAKIS
1Department of Gynaecologic Oncology, ESGO Centre of Excellence for Ovarian Cancer Surgery, St James’s University Hospital, Leeds, U.K.;
MARIOS EVANGELOS MAMALIS
2Information Systems Lab, Department of Business Administration, University of Macedonia, Thessaloniki, Greece
EVANGELOS KALAMPOKIS
2Information Systems Lab, Department of Business Administration, University of Macedonia, Thessaloniki, Greece
YONG SHENG TAN
1Department of Gynaecologic Oncology, ESGO Centre of Excellence for Ovarian Cancer Surgery, St James’s University Hospital, Leeds, U.K.;
AMUDHA THANGAVELU
1Department of Gynaecologic Oncology, ESGO Centre of Excellence for Ovarian Cancer Surgery, St James’s University Hospital, Leeds, U.K.;
TIMOTHY BROADHEAD
1Department of Gynaecologic Oncology, ESGO Centre of Excellence for Ovarian Cancer Surgery, St James’s University Hospital, Leeds, U.K.;
DAVID NUGENT
1Department of Gynaecologic Oncology, ESGO Centre of Excellence for Ovarian Cancer Surgery, St James’s University Hospital, Leeds, U.K.;
DIEDERICK DEJONG
1Department of Gynaecologic Oncology, ESGO Centre of Excellence for Ovarian Cancer Surgery, St James’s University Hospital, Leeds, U.K.;
ALEXANDROS LAIOS
1Department of Gynaecologic Oncology, ESGO Centre of Excellence for Ovarian Cancer Surgery, St James’s University Hospital, Leeds, U.K.;
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Continuity Unveiled: Evaluating Cytoreduction Outcomes for Advanced Ovarian Cancer Amidst the COVID-19 Era at an ESGO Designated Centre of Excellence
KONSTANTINOS KITSOS-KALYVIANAKIS, KONSTANTINOS PITSIKAKIS, MARIOS EVANGELOS MAMALIS, EVANGELOS KALAMPOKIS, YONG SHENG TAN, AMUDHA THANGAVELU, TIMOTHY BROADHEAD, DAVID NUGENT, DIEDERICK DEJONG, ALEXANDROS LAIOS
Anticancer Research Jun 2024, 44 (6) 2645-2652; DOI: 10.21873/anticanres.17071
Continuity Unveiled: Evaluating Cytoreduction Outcomes for Advanced Ovarian Cancer Amidst the COVID-19 Era at an ESGO Designated Centre of Excellence
KONSTANTINOS KITSOS-KALYVIANAKIS, KONSTANTINOS PITSIKAKIS, MARIOS EVANGELOS MAMALIS, EVANGELOS KALAMPOKIS, YONG SHENG TAN, AMUDHA THANGAVELU, TIMOTHY BROADHEAD, DAVID NUGENT, DIEDERICK DEJONG, ALEXANDROS LAIOS
Anticancer Research Jun 2024, 44 (6) 2645-2652; DOI: 10.21873/anticanres.17071
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.